Iterum Therapeutics to Participate in H.C. Wainwright BioConnect Virtual Conference
DUBLIN, Ireland and CHICAGO, Jan. 06, 2021 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical
Read moreNasdaq:ITRM
Iterum Therapeutics to Participate in H.C. Wainwright BioConnect Virtual Conference
DUBLIN, Ireland and CHICAGO, Jan. 06, 2021 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical
Read moreIterum Therapeutics Announces Transition of Michael Dunne, M.D. to Strategic Advisor and Member of the Board of Directors
–Dr. Dunne resigns as Chief Scientific Officer– — Steven Aronin, M.D., Senior Vice President and Head of Clinical Development, to
Read moreIterum Therapeutics Submits New Drug Application to U.S. Food and Drug Administration for Oral Sulopenem
—First Oral Penem in the U.S. and First New Oral Treatment for uUTIs in Over 20 Years, if approved–– ––Potential
Read moreIterum Therapeutics Announces Pricing of $17.5 Million Upsized Public Offering
DUBLIN, Ireland and CHICAGO, Oct. 23, 2020 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM), a clinical-stage pharmaceutical company focused
Read moreUPDATE — Iterum Therapeutics to Present Data from Phase 3 Trials in Uncomplicated and Complicated Urinary Tract Infections at IDWeek 2020
Data presentations to cover both SURE-1 and SURE-2 urinary tract infection studies DUBLIN, Ireland and CHICAGO, Oct. 19, 2020 (GLOBE
Read moreIterum Therapeutics to Present Data from Phase 3 Trials in Uncomplicated and Complicated Urinary Tract Infections at IDWeek 2020
Data presentations to cover both SURE-1 and SURE-2 urinary tract infection studies DUBLIN, Ireland and CHICAGO, Oct. 19, 2020 (GLOBE
Read moreIterum Therapeutics to Present at the 22nd Annual H.C. Wainwright Global Investment Conference
DUBLIN, Ireland and CHICAGO, Sept. 08, 2020 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company”), a clinical-stage pharmaceutical
Read moreIterum Therapeutics to Present at the 22nd Annual H.C. Wainwright Global Investment Conference
DUBLIN, Ireland and CHICAGO, Sept. 08, 2020 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company”), a clinical-stage pharmaceutical
Read moreIterum Therapeutics to Present at the 22nd Annual H.C. Wainwright Global Investment Conference
DUBLIN, Ireland and CHICAGO, Sept. 08, 2020 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company”), a clinical-stage pharmaceutical
Read more